Salivary Profiling in Infants Treated for Suspected Sepsis: The SPITSS Study

NCT05490212•Tufts Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Infection; Newborn

Interventions

Single Molecule Array (SiMoA)

Locations

United States

Locations (3)

University of Florida

Gainesville, Florida, United States

Tufts Medical Center

Boston, Massachusetts, United States

Women and Infants' Hospital

Providence, Rhode Island, United States

Key Dates

Start Date

October 3, 2019

Primary Completion Date

May 31, 2024

Completion Date

May 31, 2024

Last Updated

August 5, 2022

Contacts

Jill Maron, MD, MPH

CONTACT

401-274-1100 JMaron@Wihri.org

Anne Kurfiss, MPH

CONTACT

617-636-7134 akurfiss@tuftsmedicalcenter.org

Sponsors

Lead Sponsor

Tufts Medical Center

Collaborators

Women and Infants Hospital of Rhode Island
University of Florida
Brigham and Women's Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 5, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions